RPRX
Royalty Pharma plc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$45.65
-0.22 ▼ -0.48%
🌙 3월 13일 7:47 PM ET (한국 3/14 08:47)
$45.06
-0.59 ▼ -1.29%
| Index | - | P/E | 25.64 | EPS (ttm) | 1.78 | Insider Own | 7.35% | Shs Outstand | 0.43B | Perf Week | 0.53% |
| Market Cap | 26.34B | Forward P/E | 8.69 | EPS next Y | 8.19% | Insider Trans | -3.04% | Shs Float | 0.40B | Perf Month | 3.16% |
| Enterprise Value | 37.90B | PEG | 1.09 | EPS next Q | 1.07 | Inst Own | 85.74% | Short Float | 3.06% | Perf Quarter | 19.32% |
| Income | 0.77B | P/S | 11.07 | EPS this Y | 0.53% | Inst Trans | 3.92% | Short Ratio | 3.29 | Perf Half Y | 24.39% |
| Sales | 2.38B | P/B | 3.02 | EPS next 5Y | 8% | ROA | 4.07% | Short Interest | 12.16M | Perf YTD | 18.14% |
| Book/sh | 15.11 | P/C | 41.31 | EPS past 3/5Y | 163.11% -7.26% | ROE | 11.48% | 52W High | -4.62% ($47.86) | Perf Year | 39.69% |
| Cash/sh | 1.11 | P/FCF | 10.15 | Sales past 3/5Y | 2.06% 2.3% | ROIC | 5.12% | 52W Low | 53.91% ($29.66) | Perf 3Y | 39.3% |
| Dividend Est. | $0.98 (2.14%) | EV/EBITDA | 24.27 | EPS Y/Y TTM | -7.01% | Gross Margin | - | Volatility(W/M) | 1.87% 2.04% | Perf 5Y | -2.71% |
| Dividend TTM | 0.89 | EV/Sales | 15.94 | Sales Y/Y TTM | 5.05% | Oper. Margin | 65.56% | ATR (14) | 0.96 | Perf 10Y | - |
| Dividend Ex-Date | 2026/2/20 | Quick Ratio | 2.4 | EPS Q/Q | 6.83% | Profit Margin | 32.41% | RSI (14) | 54.98 | Recom | 1.5 |
| Dividend Gr. 3/5Y | 5.01% 24.01% | Current Ratio | 2.4 | Sales Q/Q | 4.71% | SMA20 | -0.46% ($45.86) | Beta | 0.42 | Target Price | $52.43 |
| Payout | 49.4% | Debt/Eq | 1.38 | Earnings | 2000000 | SMA50 | 5.89% ($43.11) | Rel Volume | 0.72 | Prev Close | $45.87 |
| Employees | 100 | LT Debt/Eq | 1.33 | EPS/Sales Surpr. | 14.02% 8.31% | SMA200 | 19.11% ($38.33) | Avg Volume(3M) | 3.70M | Price | $45.65 |
| IPO | 2020/6/16 | Option/Short | Yes/Yes | Trades | 22291 | Volume | 2,682,196 | Change | -0.48% |
뉴스 로딩 중...